{"id":"W4417480662","doi":"10.1016/j.jval.2025.09.668","title":"EE284 Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Vedolizumab; Disease; MEDLINE; Value (mathematics); Complete remission","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008548066,0.000392348,0.0009359038,0.0006805738,0.0003898477,0.00131015,0.0008989731,0.0007547332,0.002741819],"category_scores_gemma":[0.002723185,0.0002469608,0.002014458,0.001270748,0.0003836943,0.0002720488,0.0004774523,0.001325452,0.0002235071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02926628,"about_ca_system_score_gemma":0.018149,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.9126161,"about_ca_topic_score_gemma":0.9350909,"domain_scores_codex":[0.9988356,0.0002969321,0.00006265616,0.0001101211,0.0002969992,0.000397799],"domain_scores_gemma":[0.9986961,0.0002140598,0.000211228,0.00002808089,0.0003058911,0.0005446362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1275708,0.001134696,0.5891681,0.002021261,0.01034887,0.001094959,0.0003907613,0.02740343,0.003213783,0.005736938,0.04813382,0.1837827],"study_design_scores_gemma":[0.00623406,0.002440876,0.9617304,0.0004201192,0.00358752,0.0004909277,0.0005366705,0.008755789,0.0004924582,0.0003031396,0.01491762,0.00009043395],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9376621,0.02750612,0.0003048475,0.004559104,0.0001886849,0.0001564915,0.01848919,0.00005714924,0.01107643],"genre_scores_gemma":[0.9852967,0.003620936,0.0002720462,0.0006005454,0.00007052672,0.00004395011,0.006145229,0.00002324527,0.003926929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9126161,"threshold_uncertainty_score":0.2123427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01171200381823341,"score_gpt":0.274271300961464,"score_spread":0.2625592971432306,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}